Risk of menopause during the first year after breast cancer diagnosis

Journal of Clinical Oncology

Volumn 17, Issue 8, 1999, Pages 2365-2370

  Goodwin, Pamela J ^a   Ennis, Marguerite ^a   Pritchard, Kathleen I ^a   Trudeau, Maureen ^a   Hood, Nicky ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

ADULT; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER STAGING; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; MENOPAUSE; PARTIAL MASTECTOMY; PREMENOPAUSE; PRIORITY JOURNAL;

EID: 0032796229     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.8.2365     Document Type: Article

References (27)

1. Landis SH, Murray T, Bolden S et al: Cancer statistics, 1997. CA Cancer J Clin 48:6-30, 1998
2. Hankey BF, Miller B, Curtis R, et al: Trends in breast cancer in younger women in contrast to older women. Natl Cancer Inst Monogr 16:7-14, 1994
3. Higgins S, Huffty BG: Pregnancy and lactation after breast conserving therapy for early stage breast cancer. Cancer 73:2175-2180, 1994
4. Bines J, Oleske DM, Cobleigh MA: Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 14:1718-1729, 1996
5. Theriault RL, Sellin RV: Estrogen-replacement therapy in younger women with breast cancer. Natl Cancer Inst Monogr 16:149-152, 1994
6. Kerlikowske K: Efficacy of screening mammography among women aged 40 to 49 years and 50 to 69 years: Comparison of relative and absolute benefit. Monogr Natl Cancer Inst 22:79-86, 1997
7. Nystrom L, Rutqvist LE, Wall S, et al: Breast cancer screening with mammography: Overview of Swedish randomized trials. Lancet 341:973-978, 1993
8. Early Breast Cancer Trialists' Collaborative Group: Polychemotherapy for early breast cancer: An overview of the randomized trials. Lancet 352:930-942, 1998
9. Early Breast Cancer Trialists' Collaborative Group: Tamoxifen for early breast cancer: An overview of the randomized trials. Lancet 351:1451-1467, 1998
10. Early Breast Cancer Trialists' Collaborative Group: Ovarian ablation in early breast cancer: An overview of the randomized trials. Lancet 348:1189-1196, 1996
11. Del Mastro L, Venturini M, Sertoli MR, et al: Amenorrhea induced by adjuvant chemotherapy in early breast cancer patients: Prognostic role and clinical implications. Br Cancer Res Treat 43:183-190, 1997
12. Collichio F, Pandya K: Amenorrhea following chemotherapy for breast cancer: Effect on disease-free survival. Oncology 8:45-52, 1994
13. Rozenberg S, Vasquez JB, Vandromme J, et al: Educating patients about the benefits and drawbacks of hormone replacement therapy. Drugs Aging 13:33-41, 1998
14. Barrett-Connor E, Bush TL: Estrogen and coronary heart disease in women. JAMA 265:1861-1867, 1991
15. Barrett-Connor E: Hormone replacement therapy. BMJ 317:457-461, 1998
16. McKinney KA, Thompson W: A practical guide to prescribing hormone replacement therapy. Drugs 56:49-57, 1998
17. Cobleigh MA: Hormone replacement therapy and non-hormone control of menopausal symptoms in breast cancer survivors. Cancer Treat Res 94:209-230, 1998
18. Wile AG, Opfell RW, Magileth DA: Hormone replacement therapy in previously treated breast cancer patients. Am J Surg 165:372-375, 1993
19. Powles TJ, Hickish T, Casey S: Hormone replacement after breast cancer. Lancet 342:60-61, 1993
20. Roy JA, Sawka CA, Pritchard KI: Hormone replacement therapy in women with breast cancer: Do the risks outweigh the benefits? J Clin Oncol 14:997-1006, 1996
21. Bianco AR, Del Mastro L, Gallo C, et al: Prognostic role of amenorrhea induced by adjuvant chemotherapy in premenopausal patients with early breast cancer. Br J Cancer 63:799-803, 1991
22. Goldhirsch A, Gelber RD, Castigliore M: The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patients. Ann Oncol 1:183-188, 1990
23. Rubens RD, Knight RK, Fentiman IS, et al: Controlled trial of adjuvant chemotherapy with melphalan for breast cancer. Lancet 321:839-843, 1983
24. Cobleigh MA, Bines J, Harris D, et al: Amenorrhea following adjuvant chemotherapy for breast cancer. Proc Am Soc Clin Oncol 14:A158, 1995 (abstr)
25. Bonadonna G, Brusamolino E, Valagussa P, et al: Combination chemotherapy as adjuvant treatment in operable breast cancer. N Engl J Med 294:405-410, 1976
26. Levine MN, Bramwell V, Pritchard KI, et al: Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. J Clin Oncol 16:2651-2658, 1998
27. Goodwin PJ, Ennis M, Pritchard KI, et al: Adjuvant treatment and onset of menopause predicts weight gain after breast cancer diagnosis. J Clin Oncol 17:120-129, 1999